Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Nectar Lifesciences Financial Results

Nectar Lifesciences reported ₹9.29 Crore total income for FY2025-26. The Board also approved re-appointing two Independent Directors and withdrew the proposal to change its RTA.

Key figures
Value₹9.29 Cr
Source

BSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.34
Market cap
₹231.9 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-0.9×Sector 46.1×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →

Other financial results announcements

All →